1. Home
  2. FOR vs AMLX Comparison

FOR vs AMLX Comparison

Compare FOR & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forestar Group Inc

FOR

Forestar Group Inc

HOLD

Current Price

$25.06

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$14.34

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOR
AMLX
Founded
2005
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
FOR
AMLX
Price
$25.06
$14.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
9
Target Price
$31.75
$19.56
AVG Volume (30 Days)
118.1K
820.0K
Earning Date
04-21-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.46
EPS
0.30
N/A
Revenue
$1,662,400,000.00
$380,786,000.00
Revenue This Year
$0.52
N/A
Revenue Next Year
$7.72
N/A
P/E Ratio
$83.10
N/A
Revenue Growth
10.14
1612.94
52 Week Low
$18.00
$3.11
52 Week High
$30.74
$17.49

Technical Indicators

Market Signals
Indicator
FOR
AMLX
Relative Strength Index (RSI) 31.34 49.03
Support Level $24.05 $13.28
Resistance Level $26.00 $15.41
Average True Range (ATR) 0.87 0.96
MACD -0.47 -0.04
Stochastic Oscillator 13.78 34.13

Price Performance

Historical Comparison
FOR
AMLX

About FOR Forestar Group Inc

Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. the company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Share on Social Networks: